Updated on 2025/02/27

写真a

 
KAKEHASHI Anna
 
Organization
Graduate School of Medicine Department of Basic Medical Science Associate Professor
School of Medicine Department of Medical Science
Title
Associate Professor
Affiliation
Institute of Medcine
Other name(s)
KINOSHITA ANNA
Profile
Anna Kakehashi had entered Osaka City University Graduated School of Medicine in April, 1999 and graduated with PhD D.M.Sc. Degree in March, 2003. Thereafter, she was employed at the Department of Molecular Pathology, Osaka Metropolitan University (former Osaka City University) Graduate School of Medicine as a Research Resident, in 2007 became the Research Associate, in 2013 Lecturer, and in July 2023 Associate Professor at the Department of Molecular Pathology. Her research belongs to the field of experimental, molecular pathology and chemical carcinogenesis, mostly devoted to the investigation of mechanisms of carcinogenesis, cancer risk assessment, early detection, prevention, and treatment of cancer. The recent research is focused on virus and metabolic dysfunction-associated steatohepatitis (MASH)-related and pancreatic carcinogenesis, development of new cancer and cancer stem cell markers. In respect with internation research, her work on the risk assessment of Bioethanol (ETBE) was highly evaluated by Environmetal Protection Agency (US EPA). Furthermore, from 2020 with Chiang Mai University, School of Medicine, Thailand. Osaka Metropolitan University has received an agreement exchange subsidy project (researcher dispatch) with overseas universities.
Affiliation campus
Abeno Campus

Position

  • Graduate School of Medicine Department of Basic Medical Science 

    Associate Professor  2023.07 - Now

  • Graduate School of Medicine Department of Basic Medical Science 

    Lecturer  2013.04 - 2023.06

  • School of Medicine Department of Medical Science 

    Assistant Professor  2006.07 - 2013.03

  • School of Medicine Department of Medical Science  Japan Society for the Promotion of Science

    Research Fellow  2006.04 - 2006.06

  • School of Medicine Department of Medical Science  Ministry of Health, Labor and Welfare Subsidy Young Researcher Development and Utilization Project

    Research resident  2003.12 - 2006.03

Degree

  • Doctor of Medical Science ( Osaka City University )

  • Master of Science ( Others ) (   Saint-Petersburg State University )

Research Areas

  • Life Science / Experimental pathology  / molecular pathology, chemical carcinogenesis, cancer diagnosis,・treatment・prevention, MASH, oxidative stress, DNA damage and repair

Research Interests

  • Molecular Pathology

  • Chemical Carcinogenesis

  • Translational Research

  • Cancer Risk Assessment

  • Cancer biomarkers and molecular targets

  • Oxidative stress-DNA damage-DNA repair

  • Cancer Prevention

  • MAFLD/MASH

  • PDAC

  • Hepatocellular carcinoma

Research subject summary

  • Investigation of mechanisms of carcinogenesis: biochemical and molecular-biological analyses.
    Investigation of biomarkers and mechanisms of virus and NASH-associated liver cancer, and invasive pancreatic ductal carcinoma.
    Analysis of the proteome, metabolome alterations and biological markers in carcinogenesis.
    Oxidative stress, DNA damage and repair in carcinogenesis.
    Risk assessment of chemical carcinogens.
    Cancer Prevention.

Research Career

  • 浸潤性膵管がんの早期発見バイオ―マーカー及び発がん機序解明

    2020.04 - Now 

  • Analysis of mechanisms of NASH-associated carcinogenesis and detection of biomarkers

    NASH, liver cancer, mechanism, biomarker  Individual

    2017.04 - Now 

  • Study on mechanisms of carcinogenesis: Biochemical and molecular-biological approach

    Chemical carcinogenesis, Molecular pathology, Biochemistry  Individual

    2003.04 - Now 

  • Translational research in investigation of cancer mechanisms and novel biomarkers

    Liver cancer, pancreas cancer, lung cancer, biomarker, molecular targets, translational research  Individual

    2003.04 - Now 

  • Cancer chemoprevention

    Cancer prevention, Chemoprevention  Individual

    2003.04 - Now 

  • Oxidative stress DNA damage and repair in carcinogenesis

    Individual

    2000.04 - Now 

  • Cancer risk assessment for genotoxic and non-genotoxic carcinogens

    Cancer risk assessment, Toxicologic pathology, Molecular pathology  Individual

    1999.04 - Now 

  • Study on molecular mechanisms of arsenic carcinogenicity

    arsenic, carcinogenesis, mechanism  International Joint Research

    1999.04 - Now 

Professional Memberships

  • Japanese Association for Cancer Research

      Domestic

  • Japanese Society for Carcinogenic Pathology

      Domestic

  • Society of Toxicology (USA)

      Overseas

  • Japanese Food and Chemical Association

      Domestic

  • Japanese Toxicology Association

      Domestic

▼display all

Awards

  • 高松宮妃癌研究基金学術省

    梯アンナ

    2022.04   公益財団法人   浸潤性膵管癌の早期発見や治療のための新規バイオーマーカーおよび分子ターゲットの解明

     More details

    Country:Japan

  • 弟8回大阪市立大学女性研究者特別賞[岡村賞]

    梯アンナ

    2021.12   大阪市立大学  

     More details

    Country:Japan

  • Osaka City Medical Association President Award 2017

    Anna Kakehashi, Naomi Ishii, Takahiro Okuno, Masaki Fujioka, Min Wei, Shoji Fukushima, Hideki Wanibuchi

    2018.03   Osaka City Medical Association   Progression of Hepatic Adenoma to Carcinoma in Ogg1 Mutant Mice Induced by Phenobarbital

     More details

    Country:Japan

  • Dean Award of Excellence 2017

    2018.03   Osaka City University Graduate School of Medicine   Hepatic Adenoma to Carcinoma in Ogg1 Mutant Mice Induced by Phenobarbital Journal: Oxidative Medicine and Cellular Longevity

     More details

    Country:Japan

  • Award for young scientists from Society of Toxicology of Japan

    Anna Kakehashi

    2003.07   JTA   Carcinogenicity of low doses of phenobarbital in the rat liver: Evidence for hormesis

     More details

    Country:Japan

▼display all

Education

  • Osaka City University   Chemical carcinogenesis Cancer risk assessment Mol.pathology   Doctor's Course   Graduated/Completed

    1999 - 2003

Papers

  • Metabolism and effects of acetoaceto-<i>o</i>-toluidine in the urinary bladder of humanized-liver mice Invited

    Suzuki Shugo, Gi Min, Yanagiba Yukie, Yoneda Nao, Uehara Shotaro, Yokota Yuka, Noura Ikue, Fujioka Masaki, Vachiraarunwong Arpamas, Kakehashi Anna, Koda Shigeki, Suemizu Hiroshi, Wanibuchi Hideki

    Journal of Toxicologic Pathology   38 ( 1 )   59 - 67   2025.01( ISSN:0914-9198 ( eISSN:1881915X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    <p> Occupational exposure to aromatic amines is a major risk factor for urinary bladder cancer. Our previous studies showed that acetoaceto-<i>o</i>-toluidine, which is produced using <i>o</i>-toluidine as a raw material, promotes urinary bladder carcinogenesis in rats. We also found high concentrations of <i>o</i>-toluidine, a human bladder carcinogen, in the urine of acetoaceto-<i>o</i>-toluidine-treated rats, indicating that urinary <i>o</i>-toluidine derived from acetoaceto-<i>o</i>-toluidine may play an important role in bladder carcinogenesis. However, this has not been investigated in humans. In the present study, we used non-humanized (F1-TKm30 mice) and humanized-liver mice established by human hepatocyte transplantation to compare differences in urinary acetoaceto-<i>o</i>-toluidine metabolites produced by human and mouse liver cells. We also examined the changes in acetoaceto-<i>o</i>-toluidine-induced mRNA expression in the liver and the proliferative effects on the bladder epithelium. Urinary <i>o</i>-toluidine was detected in both non-humanized and humanized mice. Acetoaceto-<i>o</i>-toluidine metabolites in the urine, cell proliferation activities, and DNA damage in the bladder urothelium were similar in non-humanized and humanized-liver mice. RNA expression analysis revealed that CYP1A2 expression increased in the livers of humanized-liver mice, and Cyp2c29 expression (equivalent to human CYP2C9/19) increased in the livers of non-humanized mice. These data suggest that acetoaceto-<i>o</i>-toluidine may be a human carcinogen, as evidenced by the detection of urinary <i>o</i>-toluidine in acetoaceto-<i>o</i>-toluidine-treated humanized-liver mice. This animal model is important for extrapolating toxicity data from animals to humans.</p>

    DOI: 10.1293/tox.2024-0042

    PubMed

  • Urinary bladder carcinogenic potential of 4,4'-methylenebis(2-chloroaniline) in humanized-liver mice. Reviewed

    Shugo Suzuki, Min Gi, Takuma Kobayashi, Noriyuki Miyoshi, Nao Yoneda, Shotaro Uehara, Yuka Yokota, Ikue Noura, Masaki Fujioka, Arpamas Vachiraarunwong, Anna Kakehashi, Hiroshi Suemizu, Hideki Wanibuchi

    Toxicological Sciences : an official journal of the Society of Toxicology   202 ( 2 )   210 - 219   2024.12( ISSN:10966080

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Occupational exposure to 4,4'-methylenebis(2-chloroaniline) (MOCA) has been linked to an increased risk of bladder cancer among employees in Japanese plants, indicating its significance as a risk factor for urinary bladder cancer. To investigate the role of MOCA metabolism in bladder carcinogenesis, we administered MOCA to non-humanized (F1-TKm30 mice) and humanized-liver mice for 4 and 28 wk. We compared MOCA-induced changes in metabolic enzyme expression, metabolite formation, and effects on the urinary bladder epithelium in the 2 models. At week 4, MOCA exposure induced simple hyperplasia, cell proliferation, and DNA damage in the urothelium of the humanized-liver mice, whereas in the non-humanized mice, these effects were not observed. Notably, the concentration of 4-amino-4'-hydroxylamino-3,3'-dichlorodiphenylmethane (N-OH-MOCA) in the urine of humanized-liver mice was more than 10 times higher than that in non-humanized mice at the 4-wk mark. Additionally, we observed distinct differences in the expression of cytochrome P450 isoforms between the 2 models. Although no bladder tumors were detected after 28 wk of treatment in either group, these findings suggest that N-OH-MOCA significantly contributes to the carcinogenic potential of MOCA in humans.

    DOI: 10.1093/toxsci/kfae119

    PubMed

  • Fullerene and fullerene whisker are not carcinogenic to the lungs and pleura in rat long-term study after 2-week intra-tracheal intrapulmonary administration. Reviewed

    Sheema AN, Naiki-Ito A, Kakehashi A, Ahmed OHM, Alexander DB, Alexander WT, Numano T, Kato H, Goto Y, Takase H, Hirose A, Wakahara T, Miyazawa K, Takahashi S, Tsuda H

    Archives of Toxicology   98 ( 12 )   4143 - 4158   2024.12( ISSN:0340-5761

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    DOI: 10.1007/s00204-024-03863-7

    PubMed

  • Characterizing the toxicological responses to inorganic arsenicals and their metabolites in immortalized human bladder epithelial cells. Reviewed

    Arpamas Vachiraarunwong, Min Gi, Tohru Kiyono, Shugo Suzuki, Masaki Fujioka, Guiyu Qiu, Runjie Guo, Tomoki Yamamoto, Anna Kakehashi, Masayuki Shiota, Hideki Wanibuchi

    Archives of toxicology   98 ( 7 )   2065 - 2084   2024.07( ISSN:0340-5761

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Arsenic is highly toxic to the human bladder. In the present study, we established a human bladder epithelial cell line that closely mimics normal human bladder epithelial cells by immortalizing primary uroplakin 1B-positive human bladder epithelial cells with human telomerase reverse transcriptase (HBladEC-T). The uroplakin 1B-positive human bladder epithelial cell line was then used to evaluate the toxicity of seven arsenicals (iAsV, iAsIII, MMAV, MMAIII, DMAV, DMAIII, and DMMTAV). The cellular uptake and metabolism of each arsenical was different. Trivalent arsenicals and DMMTAV exhibited higher cellular uptake than pentavalent arsenicals. Except for MMAV, arsenicals were transported into cells by aquaglyceroporin 9 (AQP9). In addition to AQP9, DMAIII and DMMTAV were also taken up by glucose transporter 5. Microarray analysis demonstrated that arsenical treatment commonly activated the NRF2-mediated oxidative stress response pathway. ROS production increased with all arsenicals, except for MMAV. The activating transcription factor 3 (ATF3) was commonly upregulated in response to oxidative stress in HBladEC-T cells: ATF3 is an important regulator of necroptosis, which is crucial in arsenical-induced bladder carcinogenesis. Inorganic arsenics induced apoptosis while MMAV and DMAIII induced necroptosis. MMAIII, DMAV, and DMMTAV induced both cell death pathways. In summary, MMAIII exhibited the strongest cytotoxicity, followed by DMMTAV, iAsIII, DMAIII, iAsV, DMAV, and MMAV. The cytotoxicity of the tested arsenicals on HBladEC-T cells correlated with their cellular uptake and ROS generation. The ROS/NRF2/ATF3/CHOP signaling pathway emerged as a common mechanism mediating the cytotoxicity and carcinogenicity of arsenicals in HBladEC-T cells.

    DOI: 10.1007/s00204-024-03750-1

    PubMed

  • Elucidation of anticancer effects of Propolis Reviewed

    Kakehashi, A.

    115   3 - 3   2024.04

▼display all

Books and Other Publications

  • Qualitative and Quantitative Assessments on Low-Dose Carcinogenicity of Genotoxic Hepatocarcinogens: Dose–Response for Key Events in Rat Hepatocarcinogenesis. In: Thresholds of Genotoxic Carcinogens, From Mechanisms to Regulation,

    ( Role: Joint author)

    2016.12 

     More details

    Total pages:210   Responsible for pages:1–17  

  • Isoleucine, Leucine and Their Role in Experimental Models of Bladder Carcinogenesis. In: Branched Chain Amino Acids in Clinical Nutrition

    Wei M., Xie X-L., Yamano S., Kakehashi A., Wanibuchi H. ( Role: Joint author)

    2015 

  • Thresholds for Genotoxic Carcinogens: Evidence from Mechanism-Based Carcinogenicity Studies

    Fukushima S., Wei M., Kakehashi A., Wanibuchi H.( Role: Joint author)

    In: Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification, Chapter 8. Thresholds for Genotoxic Carcinogens: Evidence from Mechanism-Based Carcinogenicity Studies. Editors: Hsu C.-H. and Stedeford T. John Wiley & Sons, Inc., Hoboken, NJ, USA, 832 pages, pp. 207-222, 2010.  2010 

  • Neurochemistry: Cellular, Molecular and Clinical Aspects. BB-isoform of creatine kinase in amniotic fluid as a marker of brain development disorders.

    Arutjunyan A.V., Pavlova N.G., Konstantinova N.N., Pavlenko A.V.(Kakehashi A.), Kashcheeva T.K.,Lyzlova L.V., Kozina L.S., Rusina E.I., Mikhailov A.V., Shelaeva E.V.( Role: Joint author)

    1997 

     More details

    Total pages:1226   Responsible for pages:457-460  

MISC

  • 1,4-ジオキサンはin vivo変異原性陽性である その変異原性および発がん性の定量解析 Reviewed

    魏 民, 藤岡 正喜, 梯 アンナ, 奥野 高裕, 増村 健一, 能美 健彦, 松本 道治, 大森 雅子, 鰐渕 英機, 福島 昭治

    大阪市医学会雑誌   69   32 - 32   2020.12( ISSN:0386-4103

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

  • NADPH oxidase阻害剤Apocyninは酸化ストレスの抑制を介しEHEN誘発ラット腎発がんを抑制する

    藤岡正喜, 魏民, 山野荘太郎, 河内聡子, 土井賢一郎, 石井真美, 梯アンナ, 鰐渕英機

    日本酸化ストレス学会学術集会プログラム・抄録集   69th   102‐103   2016.08

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

    J-GLOBAL

  • 分子メカニズムからみた病変把握と免疫染色 病理組織のプロテオーム解析による病変マーカー開発 Reviewed

    鰐渕 英機, 梯 アンナ, 藤岡 正喜, 奥野 高裕, 魏 民

    日本組織細胞化学会 組織細胞化学   2016   175 - 189   2016.07

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

  • 膀胱癌予防のためのリスク因子の同定と発癌機序の解明 Reviewed

    立花 大和, 魏 民, 梯 アンナ, 鰐渕 英機

    日本腎泌尿器疾患予防医学研究会 日本腎泌尿器疾患予防医学研究会誌   24 ( 1 )   24 - 28   2016.03( ISSN:1347-5010

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

  • Mcl‐1蛋白を標的とする低分子抗がん物質の毒性と有効性の評価

    土井賢一郎, 鰐渕英機, 魏民, 梯アンナ, 石井真美, 山野荘太郎

    日本毒性病理学会講演要旨集   32nd   72 (JA),182 (EN)   2016

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

    J-GLOBAL

▼display all

Presentations

▼display all

Outline of collaborative research (seeds)

  • Biochemical and molecular-biological analysis of carcinogenesis mechanisms

    2005-

     More details

    Request for collaborative research:Universities etc. Research institutes

    Type of research exchange:Contract research

    Core knowledge, technology, information etc:Chemical carcinogenesis, molecular and toxicologic pathology, biochemistry

    Study on mechanisms of chemical carcinogenesis:searching for biomarkers by analysing proteomics of preneplastic and cancer lesions

  • Investigation of markers and mechanisms of virus and MASH-associated liver cancer

     More details

    Request for collaborative research:Universities etc. Research institutes

    Type of research exchange:Joint research

  • Hormesis and dose response-mediated mechanisms in carcinogenesis

    1999-

     More details

    Request for collaborative research:Universities etc. Research institutes

    Type of research exchange:Contract research, Joint research, Lecture

    Application fields / methods etc:Recently the idea of hormesis, a biphasic dose-response relationship in which a chemical exerts opposite effects dependent on the dose, has attracted interest in the field of carcinogenesis.

    Core knowledge, technology, information etc:chemical carcinogenesis, cancer risk assessment, molecular,toxicologic pathology

    Recently the idea of hormesis has attracted interest in the field of carcinogenesis.

  • Elucidation of novel early biomarkers and carcinogenic mechanisms of invasive pancreatic ductal carcinoma

     More details

    Request for collaborative research:Universities etc. Research institutes

    Type of research exchange:Joint research

Grant-in-Aid for Scientific Research

  • Elucidation of diagnostic markers for early detection of invasive pancreatic ductal carcinoma and development of new organoid culture model

    Grant-in-Aid for Scientific Research(C)  2025

  • Elucidation of diagnostic markers for early detection of invasive pancreatic ductal carcinoma and development of new organoid culture model

    Grant-in-Aid for Scientific Research(C)  2024

  • ナノマテリアルの物理化学的性状を考慮した肺、胸腔及び全身臓器における有害性の評価ならびに新規in vitro予測手法の開発(23KD1002)

    化学物質リスク研究事業  2023

  • Elucidation of diagnostic markers for early detection of invasive pancreatic ductal carcinoma and development of new organoid culture model

    Grant-in-Aid for Scientific Research(C)  2023

  • ナノマテリアルの物理化学的性状を考慮した肺、胸腔及び全身臓器における有害性の評価ならびに新規in vitro予測手法の開発 (20KD1003)

    化学物質リスク研究事業  2020.04

▼display all

Charge of on-campus class subject

  • 病理学修行実習

    2024     Undergraduate

  • 肝発がんの分子機構とバイオマーカー

    2024     Graduate school

  • 原因と病態1 病理学:副腎疾患

    2024     Undergraduate

  • 原因と病態1 病理学:膵島疾病-糖尿病と膵島腫瘍

    2024     Undergraduate

  • 原因と病態1 病理学:口腔・唾液腺・食道疾患

    2024    

▼display all